Keystone Biologics Advisory provides targeted CMC guidance to de-risk development and ensure your program is positioned for regulatory success. Our core service offerings include:
CMC Drug Development Plans
Developing integrated roadmaps that align technical milestones with regulatory expectations from early phase through to commercialization.
CMC Readiness Assessments for First-in-Human (FIH)
Conducting deep-dive evaluations to ensure manufacturing, quality, and safety data meet the threshold for clinical initiation.
CMC Gap Analysis for BLA
Identifying and remediating technical and documentation gaps in preparation for the Biologics License Application.
Comparability Exercises
Designing and over-seeing robust comparability protocols to bridge manufacturing changes and scale-up throughout the product lifecycle.
Control Strategy and Specifications Development
Establishing phase-appropriate analytical controls and scientifically justified specifications that meet latest FDA standards.
Stability Protocols and Data Review
Providing expert review of stability programs to ensure data integrity and to support shelf-life justifications for clinical and commercial products.
Keystone Biologics Advisory provides targeted CMC guidance to de-risk development and ensure your program is positioned for regulatory success. Our core service offerings include:
CMC Drug Development Plans
Developing integrated roadmaps that align technical milestones with regulatory expectations from early phase through to commercialization.
CMC Readiness Assessments for First-in-Human (FIH)
Conducting deep-dive evaluations to ensure manufacturing, quality, and safety data meet the threshold for clinical initiation.
CMC Gap Analysis for BLA
Identifying and remediating technical and documentation gaps in preparation for the Biologics License Application.
Comparability Exercises
Designing and over-seeing robust comparability protocols to bridge manufacturing changes and scale-up throughout the product lifecycle.
Control Strategy and Specifications Development
Establishing phase-appropriate analytical controls and scientifically justified specifications that meet latest FDA standards.
Stability Protocols and Data Review
Providing expert review of stability programs to ensure data integrity and to support shelf-life justifications for clinical and commercial products.
